Market Whales and Their Recent Bets on GILD Options
Market Whales and Their Recent Bets on GILD Options
Financial giants have made a conspicuous bullish move on Gilead Sciences. Our analysis of options history for Gilead Sciences (NASDAQ:GILD) revealed 13 unusual trades.
金融巨頭對吉利德科學採取了明顯的看漲舉動。我們對吉利德科學（納斯達克股票代碼：GILD）期權歷史的分析顯示了13筆不尋常的交易。
Delving into the details, we found 61% of traders were bullish, while 23% showed bearish tendencies. Out of all the trades we spotted, 7 were puts, with a value of $495,955, and 6 were calls, valued at $263,160.
深入研究細節，我們發現61％的交易者看漲，而23％的交易者表現出看跌傾向。在我們發現的所有交易中，有7筆是看跌期權，價值爲495,955美元，6筆是看漲期權，價值263,160美元。
Predicted Price Range
預測的價格區間
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $55.0 to $90.0 for Gilead Sciences over the recent three months.
根據交易活動，看來重要投資者的目標是在最近三個月中將吉利德科學的價格範圍從55.0美元擴大到90.0美元。
Volume & Open Interest Development
交易量和未平倉合約的發展
In today's trading context, the average open interest for options of Gilead Sciences stands at 1270.25, with a total volume reaching 3,306.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Gilead Sciences, situated within the strike price corridor from $55.0 to $90.0, throughout the last 30 days.
在當今的交易背景下，吉利德科學期權的平均未平倉合約爲1270.25，總成交量達到3,306.00。隨附的圖表描繪了過去30天內吉利德科學高價值交易的看漲和看跌期權交易量以及未平倉合約的變化，行使價走勢從55.0美元到90.0美元不等。
Gilead Sciences Option Activity Analysis: Last 30 Days
吉利德科學期權活動分析：過去 30 天
Noteworthy Options Activity:
值得注意的期權活動：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GILD | PUT | SWEEP | BULLISH | 01/17/25 | $4.05 | $3.9 | $3.9 | $65.00 | $102.9K | 2.5K | 266 |
| GILD | CALL | SWEEP | BULLISH | 06/20/25 | $4.95 | $4.85 | $4.95 | $72.50 | $95.0K | 122 | 194 |
| GILD | PUT | SWEEP | BEARISH | 11/15/24 | $5.55 | $5.45 | $5.55 | $70.00 | $90.4K | 428 | 172 |
| GILD | PUT | TRADE | BEARISH | 06/20/25 | $2.3 | $2.12 | $2.3 | $55.00 | $75.8K | 1.0K | 332 |
| GILD | PUT | TRADE | BEARISH | 01/17/25 | $1.21 | $1.17 | $1.2 | $55.00 | $63.6K | 2.4K | 530 |
| 符號 | 看跌/看漲 | 交易類型 | 情緒 | Exp。日期 | 問 | 出價 | 價格 | 行使價 | 總交易價格 | 未平倉合約 | 音量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 金 | 放 | 掃 | 看漲 | 01/17/25 | 4.05 美元 | 3.9 美元 | 3.9 美元 | 65.00 美元 | 102.9 萬美元 | 2.5K | 266 |
| 金 | 打電話 | 掃 | 看漲 | 06/20/25 | 4.95 美元 | 4.85 美元 | 4.95 美元 | 72.50 美元 | 95.0 萬美元 | 122 | 194 |
| 金 | 放 | 掃 | 粗魯的 | 11/15/24 | 5.55 美元 | 5.45 美元 | 5.55 美元 | 70.00 美元 | 90.4 萬美元 | 428 | 172 |
| 金 | 放 | 貿易 | 粗魯的 | 06/20/25 | 2.3 美元 | 2.12 美元 | 2.3 美元 | 55.00 美元 | 75.8 萬美元 | 1.0K | 332 |
| 金 | 放 | 貿易 | 粗魯的 | 01/17/25 | 1.21 美元 | 1.17 | 1.2 美元 | 55.00 美元 | 63.6 萬美元 | 2.4K | 530 |
About Gilead Sciences
關於吉利德科學
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
吉利德科學開發和銷售治療危及生命的傳染病的療法，其產品組合的核心集中在艾滋病毒以及乙型和丙型肝炎上。對Corus Pharma、Myogen、CV Therapeutics、Arresto Biosciences和Calistoga的收購擴大了這一關注範圍，將肺部和心血管疾病以及癌症包括在內。吉利德對Pharmasset的收購帶來了丙型肝炎藥物Sovaldi的版權，該藥物也是複方藥物Harvoni的一部分，而對Kite、Forty Seven和Immunomedics的收購增加了吉利德在腫瘤學領域接受細胞療法和非細胞療法的機會。
In light of the recent options history for Gilead Sciences, it's now appropriate to focus on the company itself. We aim to explore its current performance.
鑑於吉利德科學最近的期權歷史，現在應該專注於公司本身。我們的目標是探索其目前的表現。
Present Market Standing of Gilead Sciences
吉利德科學目前的市場地位
- With a volume of 1,845,363, the price of GILD is up 0.09% at $67.71.
- RSI indicators hint that the underlying stock may be approaching overbought.
- Next earnings are expected to be released in 78 days.
- GILD的交易量爲1,845,363美元，上漲0.09％，至67.71美元。
- RSI指標暗示標的股票可能接近超買。
- 下一份業績預計將在78天后公佈。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Gilead Sciences with Benzinga Pro for real-time alerts.
交易期權涉及更大的風險，但也提供了更高利潤的潛力。精明的交易者通過持續的教育、戰略貿易調整、利用各種指標以及隨時關注市場動態來降低這些風險。使用Benzinga Pro了解吉利德科學的最新期權交易，以獲取實時警報。
譯文內容由第三人軟體翻譯。